Specifically, ablation of LGR-5+ CSCs halted tumor growth, whereas the tumors resumed growth following the removal of the cell death inducers due to the re-emergence of CSCs from differentiated tumor cells (109, 110). This evidence concerns the gene LGR5 and neoplasm.